LIR-containing proteins in Mus musculus>> EXPORT DATA
| S.No. | Uniprot ID | Start | End | LIR Sequence | PSSM Score ▲ ▼ | Similar LIR Motifs | Molecular Function | Biological Process | Cellular Component |
| 1701 | P09803 | 341 | 346 | PTYTLV | 10 | protein binding (GO:0005515) |
protein metabolic process (GO:0019538) |
apical part of cell (GO:0045177); cell surface (GO:0009986); endosome (GO:0005768); Golgi apparatus (GO:0005794) |
|
| 1702 | P09803 | 413 | 418 | AVYTVV | 7 | protein binding (GO:0005515) |
protein metabolic process (GO:0019538) |
apical part of cell (GO:0045177); cell surface (GO:0009986); endosome (GO:0005768); Golgi apparatus (GO:0005794) |
|
| 1703 | P09803 | 561 | 566 | STYVAL | 13 | protein binding (GO:0005515) |
protein metabolic process (GO:0019538) |
apical part of cell (GO:0045177); cell surface (GO:0009986); endosome (GO:0005768); Golgi apparatus (GO:0005794) |
|
| 1704 | P0C027 | 92 | 97 | RTYVFV | 13 | ATG1_YEAST(427-432) REYVVV(4) | |||
| 1705 | P0C028 | 92 | 97 | RTYVFV | 13 | ATG1_YEAST(427-432) REYVVV(4) | metabolic process (GO:0008152) |
||
| 1706 | P0C5K0 | 299 | 304 | AVFDVL | 8 | FYCO1_HUMAN(1278-1283) AVFDII(4) | |||
| 1707 | P0C5K0-2 | 280 | 285 | AVFDVL | 8 | FYCO1_HUMAN(1278-1283) AVFDII(4) | |||
| 1708 | P10287 | 156 | 161 | SGWLLL | 18 | CBL_HUMAN(800-805) FGWLSL(4) | |||
| 1709 | P10493 | 293 | 298 | EDYDLV | 16 | extracellular matrix binding (GO:0050840); protein binding (GO:0005515) |
extracellular region (GO:0005576) |
||
| 1710 | P10637 | 16 | 21 | GDYTLL | 15 | protein binding (GO:0005515) |
nucleus (GO:0005634) |
||
| 1711 | P10637-2 | 16 | 21 | GDYTLL | 15 | ||||
| 1712 | P10637-3 | 16 | 21 | GDYTLL | 15 | ||||
| 1713 | P10637-4 | 16 | 21 | GDYTLL | 15 | ||||
| 1714 | P10637-5 | 16 | 21 | GDYTLL | 15 | ||||
| 1715 | P10637-6 | 16 | 21 | GDYTLL | 15 | ||||
| 1716 | P10711 | 156 | 161 | DDYVAI | 19 | ATG13_HUMAN(442-447) DDFVMI(4) | protein binding (GO:0005515) |
||
| 1717 | P10711-2 | 121 | 126 | DDYVAI | 19 | ATG13_HUMAN(442-447) DDFVMI(4) | |||
| 1718 | P10923 | 129 | 134 | DTFTPI | 13 | extracellular matrix binding (GO:0050840) |
cell adhesion (GO:0007155) |
apical part of cell (GO:0045177); extracellular region (GO:0005576) |
|
| 1719 | P11088 | 314 | 319 | GGYESI | 12 | ||||
| 1720 | P12660 | 73 | 78 | PGFQPI | 10 | neuronal cell body (GO:0043025) |
|||
| 1721 | P12968 | 88 | 93 | LDFLLV | 12 | Q8MQJ7_DROME(389-394) DDFVLV(4); ULK2_HUMAN(351-356) DDFVLV(4) |
neuronal cell body (GO:0043025) |
||
| 1722 | P13020 | 470 | 475 | DSYIIL | 15 | FUND1_HUMAN(16-21) DSYEVL(4) | protein binding (GO:0005515) |
vesicle-mediated transport (GO:0016192) |
extracellular region (GO:0005576); protein complex (GO:0043234) |
| 1723 | P13020-2 | 421 | 426 | DSYIIL | 15 | FUND1_HUMAN(16-21) DSYEVL(4) | |||
| 1724 | P13346 | 211 | 216 | LEFVLV | 10 | Q8MQJ7_DROME(389-394) DDFVLV(4); ULK2_HUMAN(351-356) DDFVLV(4) |
nucleus (GO:0005634) |
||
| 1725 | P13405 | 49 | 54 | PEFIAL | 11 | protein binding (GO:0005515) |
cell division (GO:0051301) |
nucleus (GO:0005634); transcription factor complex (GO:0005667) |
|
| 1726 | P13808 | 318 | 323 | EVFVEL | 9 | membrane (GO:0016020) |
|||
| 1727 | P13808-2 | 304 | 309 | EVFVEL | 9 | ||||
| 1728 | P13808-3 | 309 | 314 | EVFVEL | 9 | ||||
| 1729 | P13808-4 | 120 | 125 | EVFVEL | 9 | ||||
| 1730 | P13808-5 | 152 | 157 | EVFVEL | 9 | ||||
| 1731 | P14106 | 7 | 12 | EVWTHL | 14 | SQSTM_HUMAN(336-341) DDWTHL(4) | extracellular region (GO:0005576) |
||
| 1732 | P14106 | 17 | 22 | LGFLHV | 8 | extracellular region (GO:0005576) |
|||
| 1733 | P14211 | 198 | 203 | DDWDFL | 26 | CALR_HUMAN(198-203) DDWDFL(6); CLH1_HUMAN(512-517) PDWIFL(4); SQSTM_HUMAN(336-341) DDWTHL(4) |
carbohydrate binding (GO:0030246); hormone binding (GO:0042562); peptide binding (GO:0042277); protein binding (GO:0005515) |
endoplasmic reticulum (GO:0005783); extracellular matrix (GO:0031012); extracellular region (GO:0005576); Golgi apparatus (GO:0005794); MHC class I peptide loading complex (GO:0042824); nucleus (GO:0005634); polysome (GO:0005844) |
|
| 1734 | P14753 | 365 | 370 | DTYLVL | 15 | FUND1_HUMAN(16-21) DSYEVL(4) | protein binding (GO:0005515) |
viral process (GO:0016032) |
extracellular region (GO:0005576) |
| 1735 | P14753 | 423 | 428 | FEYTIL | 14 | protein binding (GO:0005515) |
viral process (GO:0016032) |
extracellular region (GO:0005576) |
|
| 1736 | P14873 | 835 | 840 | KDFEEL | 16 | TBCD5_HUMAN(57-62) KEWEEL(4) | hydrolase activity (GO:0016787); protein binding (GO:0005515) |
synapse (GO:0045202) |
|
| 1737 | P14873 | 2351 | 2356 | PVYLDL | 7 | hydrolase activity (GO:0016787); protein binding (GO:0005515) |
synapse (GO:0045202) |
||
| 1738 | P15508 | 2115 | 2120 | SSWESL | 19 | BNI3L_HUMAN(34-39) SSWVEL(4) | membrane (GO:0016020) |
||
| 1739 | P16283 | 319 | 324 | EVFVEL | 9 | ||||
| 1740 | P16283-2 | 319 | 324 | EVFVEL | 9 | ||||
| 1741 | P16283-3 | 319 | 324 | EVFVEL | 9 | ||||
| 1742 | P16872 | 399 | 404 | PVYQDL | 7 | cell growth (GO:0016049) |
|||
| 1743 | P17012 | 204 | 209 | EDYLMI | 18 | NBR1_HUMAN(730-735) EDYIII(4) | nucleus (GO:0005634) |
||
| 1744 | P18111 | 46 | 51 | AGYTHV | 10 | nucleus (GO:0005634) |
|||
| 1745 | P18654 | 385 | 390 | FSFVAI | 12 | OPTN_HUMAN(176-181) DSFVEI(4) | cell cycle (GO:0007049) |
nucleus (GO:0005634) |
|
| 1746 | P19467 | 2 | 7 | KGFLLL | 10 | extracellular region (GO:0005576) |
|||
| 1747 | P20293 | 426 | 431 | ASWTPV | 16 | protein binding (GO:0005515) |
nucleus (GO:0005634) |
||
| 1748 | P20357 | 1249 | 1254 | GEYDKL | 13 | protein binding (GO:0005515) |
cell body (GO:0044297); intracellular (GO:0005622); neuron projection (GO:0043005); neuronal cell body (GO:0043025) |
||
| 1749 | P20357 | 1295 | 1300 | DDFITV | 17 | Q8MQJ7_DROME(389-394) DDFVLV(4); ULK1_HUMAN(355-360) DDFVMV(4); ULK2_HUMAN(351-356) DDFVLV(4) |
protein binding (GO:0005515) |
cell body (GO:0044297); intracellular (GO:0005622); neuron projection (GO:0043005); neuronal cell body (GO:0043025) |
|
| 1750 | P20764 | 172 | 177 | SSYLTL | 13 | protein binding (GO:0005515) |
extracellular region (GO:0005576) |